An investigation on behalf of investors in Endologix, Inc. (NASDAQ:ELGX) shares over potential wrongdoing at Endologix, Inc. was announced and NASDAQ:ELGX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/03/2017 -- An investigation was announced for long-term investors in shares of Endologix, Inc. (NASDAQ:ELGX) was announced over potential breaches of fiduciary duties by certain directors.
Investors who purchased shares of Endologix, Inc. (NASDAQ:ELGX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Endologix directors breached their fiduciary duties and caused damage to the company and its shareholders.
On December 27, 2016, Endologix, Inc announced a temporary hold on shipments of its AFX® Endovascular AAA System to complete an investigation of a manufacturing issue with some sizes of the device. Shares of Endologix, Inc. (NASDAQ:ELGX) declined to as low as $4.78 per share on December 28, 2016.
Those who purchased shares of Endologix, Inc. have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com